MediPharm Labs Declares their Financial Status in the Fourth Quarter of 2018

The firm is well known for its renowned skills in specialized and research-driven cannabis extraction, distillation, purification and cannabinoid separation, declares its fourth quarter and full year financial results at the end of the year on 31^st December 2018. Management’s discussion and consolidated financial statements are available on SEDAR in audited form. In the words of Chief Executive Officer, Patrick McCutcheon: “2018....